Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,940,972
-$5,507 QoQ
Shares Held
11,580
-3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.78%
of 13F equity value
Holder Rank
#2,019
of 4,664 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Wealth Partners LLC holds $9,914,904 across 8 Drug Manufacturers - General names. JNJ ranks #1 (29.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
11,580 | $2,940,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
18,313 | $2,313,664 | |
| 3 | ABBV |
AbbVie Inc.
|
6,948 | $1,748,394 | |
| 4 | LLY |
ELI LILLY & Co
|
1,132 | $1,357,754 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,447 | $828,439 | |
| 6 | PFE |
Pfizer Inc
|
11,587 | $279,014 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,220 | $243,156 | |
| 8 | AMGN |
Amgen Inc
|
562 | $203,511 |
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,940,972 | 11,580 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,946,479 | 12,054 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,482,158 | 11,994 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,215,398 | 11,948 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,598,223 | 10,463 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,835,848 | 11,070 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,093,229 | 14,474 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,242,748 | 13,839 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,773,943 | 12,137 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,972,629 | 12,470 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,928,372 | 12,303 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,931,923 | 12,404 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,439,930 | 14,741 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,354,760 | 15,192 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,540,050 | 14,379 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||